Streetbeat News

Products Services

ENPH

FSLR

SEDG

SPWR

Solar stocks are up after a report that two solar companies are developing American-made panels, potentially making US solar projects eligible for federal subsidies.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 6:10 pm

MSFT

Phil Spencer, CEO of Microsoft's Gaming division, expressed concerns about the gaming industry's challenges, including soaring production costs, reduced creativity due to financial pressures, and market stagnation. He highlighted the difficulty in balancing profit margins with consumer demand and the impact of high game development costs on console exclusivity. Spencer also addressed the broader challenges faced by the industry, including layoffs at Activision Blizzard King, and emphasized his desire for the industry to be a viable career path.

Portfolio Pulse from Franca Quarneti

March 27, 2024 | 6:07 pm

PFE

Financial analysis reveals a bullish sentiment among big money traders on Pfizer (NYSE:PFE), with 66% of observed options trades being bullish. The analysis, based on 15 unusual trades, shows a preference for calls over puts, indicating expectations for Pfizer's stock to rise. The targeted price range for these options is between $20.0 and $50.0. Pfizer, a leading pharmaceutical company with annual sales nearing $50 billion, is currently experiencing a slight increase in stock price to $27.7, with an upcoming earnings release in 35 days.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 5:46 pm

NKE

Wedbush analyst Tom Nikic reiterates an Outperform rating on Nike Inc (NYSE:NKE) with a price target of $115, highlighting the successful launch of the Air Max DN model. The product sold out on Nike.com, marking a positive development for Nike, which has faced challenges in product innovation and competition. The analyst emphasizes the importance of continuous innovation and points to the upcoming Investor Day as a potential positive catalyst.

Portfolio Pulse from Shivani Kumaresan

March 27, 2024 | 5:46 pm

AZN

CVS

SNY

WBA

On Wednesday, Japan approved AstraZeneca Plc (NASDAQ:AZN) and Sanofi SA's (NASDAQ:SNY) Beyfortus for RSV in neonates, infants, and children, expected to be available for the 2024/25 RSV season. Additionally, AstraZeneca's Truqap was approved in Japan for certain breast cancers. AstraZeneca is also suing Arkansas over a law extending federal drug discounts to for-profit pharmacy chains like CVS Health Corp (NYSE:CVS) and Walgreens Boots Alliance Inc (NASDAQ:WBA), arguing it infringes on federal law and constitutional rights.

Portfolio Pulse from Vandana Singh

March 27, 2024 | 5:42 pm

MRK

The FDA approved Merck & Co Inc's Winrevair (sotatercept) for pulmonary arterial hypertension, expected to be a key catalyst for Merck's stock in 2024. Cantor Fitzgerald maintains an Overweight rating on MRK with a price target of $135, citing the drug's approval and potential sales impact. Merck's stock has outperformed the S&P 500 year-to-date, and the successful launch of sotatercept could lead to upward earnings revisions and stock multiple expansion. Approximately 40,000 U.S. patients could benefit from sotatercept, with Merck establishing a dedicated business unit for the drug.

Portfolio Pulse from Vandana Singh

March 27, 2024 | 5:38 pm

COQUSD

DOGEUSD

WIFUSD

Crypto trader Mayne discussed turning $100,000 into $1 million using meme coins Dogecoin (DOGE) and Dogwifhat (WIF), with price targets of $1 and $4 respectively. Other traders suggested various strategies and alternative coins like Coq Inu (COQ), Popcat (POPCAT), MOG Coin (MOG), and SLERF (SLERF).

Portfolio Pulse from Khyathi Dalal

March 27, 2024 | 5:32 pm

BTCUSD

Pseudonymous cryptocurrency trader CryptoJelle shared a market structure analysis strategy on X, which helped him avoid the 2021 Bitcoin crash from $58K to $28K. This technique involves identifying trends through the analysis of market highs and lows, aiding in the anticipation of market shifts. CryptoJelle emphasizes the importance of observing higher timeframes for significant trend changes and advises against making hasty decisions based on short-term chart movements.

Portfolio Pulse from Khyathi Dalal

March 27, 2024 | 5:17 pm

ACN

MSFT

Accenture Plc (ACN) and Microsoft Corporation (MSFT) announced a partnership to launch a 'Cloud Modernization and Migration Factory' on Microsoft Azure Government for national security. This initiative aims to streamline the onboarding of remote federal sites to Azure Government Secret and Top Secret classified clouds, ensuring the highest level of security. The collaboration will also leverage Generative AI-powered migration tools for faster cloud modernization, meeting the stringent security criteria required for national security operations.

Portfolio Pulse from Nabaparna Bhattacharya

March 27, 2024 | 4:43 pm

BYDDF

BYDDY

BYD Company aims to significantly increase its international sales of electric vehicles (EVs) to 500,000 units in 2024, doubling from the previous year, with a goal to reach 3.6 million units in total sales. This ambitious target comes amid a period of slowing profit growth and increased competition in the EV market. Despite a potential drop in vehicle margins due to price competition, BYD is focused on profitability through enhanced sales strategies and the introduction of new, more efficient models.

Portfolio Pulse from Shivani Kumaresan

March 27, 2024 | 4:36 pm